Royal Bank of Canada
APTO

Royal Bank of Canada’s Aptose Biosciences, Inc. APTO Stock Holding History

Royal Bank of Canada’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,351
Closed -$4K – 7509
2025
Q1 		$4K Buy
1,351
+1,329
+6,041% +$6.46K ﹤0.01% 6455
2024
Q4 		$0 Sell
22
-36
-62% -$328 ﹤0.01% 7445
2024
Q3 		$1K Sell
58
-16
-22% -$244 ﹤0.01% 6770
2024
Q2 		$2K Buy
74
+28
+61% +$950 ﹤0.01% 6770
2024
Q1 		$2K Sell
46
-179
-80% -$10.2K ﹤0.01% 6737
2023
Q4 		$17K Buy
225
+201
+838% +$15.6K ﹤0.01% 6369
2023
Q3 		$2K Sell
24
-27
-53% -$3.18K ﹤0.01% 6844
2023
Q2 		$8K Buy
51
+25
+96% +$5.17K ﹤0.01% 6558
2023
Q1 		$7K Sell
26
-5
-16% -$1.45K ﹤0.01% 6483
2022
Q4 		$8K Sell
31
-1
-3% -$269 ﹤0.01% 6634
2022
Q3 		$9K Buy
32
+10
+45% +$3.45K ﹤0.01% 6503
2022
Q2 		$8K Hold
22
– – ﹤0.01% 6493
2022
Q1 		$14K Sell
22
-3
-12% -$1.66K ﹤0.01% 6816
2021
Q4 		$16K Sell
25
-10
-29% -$9.4K ﹤0.01% 6899
2021
Q3 		$34K Buy
35
+2
+6% +$2.5K ﹤0.01% 6390
2021
Q2 		$49K Buy
33
+4
+14% +$8.71K ﹤0.01% 6063
2021
Q1 		$77K Hold
29
– – ﹤0.01% 5630
2020
Q4 		$58K Sell
29
-13
-31% -$30.5K ﹤0.01% 5607
2020
Q3 		$113K Buy
42
+2
+5% +$4.99K ﹤0.01% 4896
2020
Q2 		$114K Buy
40
+14
+54% +$45.2K ﹤0.01% 4776
2020
Q1 		$69K Buy
26
+6
+30% +$17.9K ﹤0.01% 4989
2019
Q4 		$52K Sell
20
-7
-26% -$9.12K ﹤0.01% 5443
2019
Q3 		$24K Buy
27
+2
+8% +$2.28K ﹤0.01% 5426
2019
Q2 		$30K Sell
25
-7
-22% -$6.44K ﹤0.01% 5518
2019
Q1 		$29K Hold
32
– – ﹤0.01% 5472
2018
Q4 		$28K Sell
32
-11
-26% -$10.8K ﹤0.01% 5424
2018
Q3 		$50K Buy
43
+2
+5% +$2.68K ﹤0.01% 5240
2018
Q2 		$74K Sell
41
-4
-9% -$6.38K ﹤0.01% 4977
2018
Q1 		$65K Hold
45
– – ﹤0.01% 4927
2017
Q4 		$45K Sell
45
-19
-30% -$14.7K ﹤0.01% 5222
2017
Q3 		$43K Sell
64
-2
-3% -$1.34K ﹤0.01% 5509
2017
Q2 		$36K Sell
66
-5
-7% -$2.41K ﹤0.01% 5284
2017
Q1 		$33K Sell
71
-1
-1% -$512 ﹤0.01% 5374
2016
Q4 		$45K Buy
72
+26
+57% +$16.2K ﹤0.01% 5321
2016
Q3 		$46K Buy
46
+21
+84% +$21.8K ﹤0.01% 5195
2016
Q2 		$27K Sell
25
-7
-22% -$8.26K ﹤0.01% 5385
2016
Q1 		$42K Sell
32
-12
-27% -$14.3K ﹤0.01% 5201
2015
Q4 		$51K Buy
44
+6
+16% +$10.6K ﹤0.01% 5300
2015
Q3 		$72K Hold
38
– – ﹤0.01% 4953
2015
Q2 		$87K Sell
38
-18
-32% -$47.1K ﹤0.01% 4908
2015
Q1 		$137K Buy
56
+47
+522% +$114K ﹤0.01% 4449
2014
Q4 		$23K Buy
+9
New +$27.1K ﹤0.01% 5365

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

Royal Bank of Canada's APTO Position: Q2 2025 in Review

Royal Bank of Canada sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 1,351 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in APTO in Q4 2014 and held it in 42 quarters. The position peaked at $137K in Q1 2015. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • Royal Bank of Canada reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 1,351 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $4K.
  • Royal Bank of Canada first reported a position in Aptose Biosciences, Inc. in Q4 2014 and held it in 42 quarters.
  • Royal Bank of Canada's Aptose Biosciences, Inc. position peaked at $137K in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.